In the landscape of medical innovation, there exists a critical pathway that bridges the gap between experimental treatments and approved therapies. Named Patient Programs (NPPs) represent one of the most important mechanisms for delivering promising but not-yet-approved medications to patients facing life-threatening conditions. These programs serve as lifelines for individuals who have exhausted conventional treatment options and cannot wait for the lengthy process of full regulatory approval....
Published on May 06, 2025 04:12